Status:
COMPLETED
Study to Examine the Effects of MultiStem in Ischemic Stroke
Lead Sponsor:
Healios K.K.
Collaborating Sponsors:
Medpace, Inc.
Conditions:
Ischemic Stroke
Eligibility:
All Genders
18-83 years
Phase:
PHASE2
Brief Summary
A study to examine the safety and potential effectiveness of the adult stem cell investigational product, MultiStem, in adults who have suffered an ischemic stroke. The hypothesis is that MultiStem wi...
Eligibility Criteria
Inclusion
- Male or female subjects between 18 and 83 years of age (inclusive)
- Clinical diagnosis of cortical cerebral ischemic stroke
- Occurrence of a moderate to moderately severe stroke
Exclusion
- Presence of a lacunar or a brainstem infarct
- Reduced level of consciousness
- Major neurological event such as stroke or clinically significant head trauma within 6 months of study
Key Trial Info
Start Date :
October 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2015
Estimated Enrollment :
134 Patients enrolled
Trial Details
Trial ID
NCT01436487
Start Date
October 1 2011
End Date
December 1 2015
Last Update
August 2 2016
Active Locations (32)
Enter a location and click search to find clinical trials sorted by distance.
1
UCLA Medical Center
Los Angeles, California, United States, 90095
2
Stanford University
Stanford, California, United States, 94305
3
University of Miami
Miami, Florida, United States, 33136
4
Florida Hospital Orlando
Orlando, Florida, United States, 32803